Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|14|1|52-62

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.14, Iss.1, 2014-02, pp. : 52-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics

By  

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 424-429

Bentham Science Publishers

Access to resources Recommend Favorite

Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy

By  

Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. : 78-83

Bentham Science Publishers

Access to resources Recommend Favorite

Life or Death of T Cells with Antigen-Specific Receptors - Using T Cells for Cancer Adoptive Immunotherapy / Gene Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 3, 2001-09 ,pp. : 253-255

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes

By  

Current Gene Therapy, Vol. 9, Iss. 5, 2009-10 ,pp. : 396-408

Bentham Science Publishers

Access to resources Recommend Favorite

Adoptive immunotherapy eradicates cancer in mice

By  

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite